Great Point Partners LLC Portfolio Holdings

Great Point Partners LLC

  • $121 Million
  • Q2 2025

Great Point Partners LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $121 Million distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ionis Pharmaceuticals Inc with a value of $19.8M, Rezolute, Inc. with a value of $13.5M, Amylyx Pharmaceuticals, Inc. with a value of $12.8M, Legend Biotech Corp with a value of $12.4M, and Akebia Therapeutics, Inc. with a value of $7.23M.

Examining the 13F form we can see an decrease of $41.2M in the current position value, from $162M to 121M.

Great Point Partners LLC is based out at Greenwich, CT

Below you can find more details about Great Point Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $121 Million
Healthcare: $119 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$10.9M
$3.09 Million 2.56% of portfolio
4,683,711
Q4 2024 Reduced 32.46%
$0
$1.27 Million 1.05% of portfolio
2,645,128
Q4 2024 Reduced 5.22%

Summary

  • Portfolio
  • No. of Stocks 26
  • Current Value $121 Million
  • Prior Value $162 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 6 stocks
  • Additional Purchases 7 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email